{"id":"W4387824968","doi":"10.1016/j.annonc.2023.09.2005","title":"859MO Sacituzumab govitecan (SG) in patients (pts) with relapsed/refractory (R/R) advanced head and neck squamous cell carcinoma (HNSCC): Results from the phase II TROPiCS-03 basket trial","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Adverse effect; Head and neck squamous-cell carcinoma; Refractory (planetary science); Phases of clinical research; Cohort; Surgery; Oncology; Clinical trial; Head and neck cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000496001,0.000555408,0.001013322,0.0002025904,0.0001817138,0.0007322633,0.0003621061,0.0004909522,0.00271997],"category_scores_gemma":[0.0003132594,0.0001947045,0.0006854805,0.0003699229,0.000396342,0.0005267514,0.000243431,0.001344367,0.0008613006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005664426,"about_ca_system_score_gemma":0.0007027954,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001582354,"about_ca_topic_score_gemma":0.006751203,"domain_scores_codex":[0.9998765,0.00004074767,0.000005392248,0.00002375449,0.00001348236,0.00004014027],"domain_scores_gemma":[0.9998645,0.00001782394,0.00002544825,0.000009672535,0.000008287162,0.00007421444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5761712,0.009702847,0.02811353,0.001257068,0.002806967,0.0003387172,0.0003571843,0.005633566,0.03536529,0.0008416433,0.01539099,0.3240211],"study_design_scores_gemma":[0.5560367,0.2962067,0.1081921,0.0002686099,0.003070647,0.001003182,0.0004198275,0.004832994,0.005398652,0.001712048,0.02278921,0.00006934196],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927629,0.003157177,0.0001146734,0.0004589341,0.00009589691,0.0002039005,0.000821998,0.00007007937,0.002314512],"genre_scores_gemma":[0.9907649,0.002845805,0.0003394474,0.0007958964,0.00009853682,0.000167895,0.002433891,0.00002291306,0.002530855],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00271997,"threshold_uncertainty_score":0.009099185,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06312735777555628,"score_gpt":0.3723666057780799,"score_spread":0.3092392480025236,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}